Exodus Point Capital Management, LP Ionis Pharmaceuticals Inc Transaction History

Exodus Point Capital Management, LP

$9.1 Billion
Q3 2025

A detailed history of Exodus Point Capital Management, LP transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 152,125 shares of IONS stock, worth $10.9 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

152,125

Holding current value

$10.9 Million

% of portfolio

0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$39.94 - $65.42 $6.08 Million - $9.95 Million	152,125 New	152,125 $9.95 Million
Q1 2025 May 14, 2025	BUY	$30.17 - $34.97 $792,294 - $918,347	26,261 New	26,261 $792,000
Q2 2024 Aug 13, 2024	SELL	$36.45 - $47.7 $244,178 - $319,542	-6,699 Reduced 3.1%	209,194 $9.97 Million
Q1 2024 May 14, 2024	BUY	$42.03 - $53.55 $9.07 Million - $11.6 Million	215,893 New	215,893 $9.36 Million
Q1 2023 May 11, 2023	SELL	$33.58 - $41.2 $1.31 Million - $1.61 Million	-39,060 Reduced 12.83%	265,330 $9.48 Million

Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $11.1 Million - $13.9 Million	297,973 Added 4643.49%	304,390 $11.5 Million
Q3 2022 Nov 10, 2022	SELL	$36.54 - $48.66 $1.14 Million - $1.52 Million	-31,173 Reduced 82.93%	6,417 $284,000
Q2 2022 Aug 19, 2022	BUY	$31.71 - $43.0 $1.19 Million - $1.62 Million	37,590 New	37,590 $1.39 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $591,265 - $732,947	-19,788 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $297,460 - $407,686	11,615 Added 142.11%	19,788 $602,000
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $274,122 - $331,415	8,173 New	8,173 $274,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $1.2 Million - $1.6 Million	-26,507 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$47.45 - $62.95 $1.26 Million - $1.67 Million	26,507 New	26,507 $1.26 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $278,007 - $362,270	-5,934 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $53,248 - $81,152	1,280 Added 27.5%	5,934 $281,000
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $250,617 - $303,766	4,654 New	4,654 $281,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $3.94 Million - $5.47 Million	-63,522 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $3.07 Million - $4.71 Million	58,022 Added 1054.95%	63,522 $5.16 Million
Q4 2018 Feb 14, 2019	BUY	$43.37 - $59.54 $238,535 - $327,470	5,500 New	5,500 $297,000

Others Institutions Holding IONS

# of Institutions

508

Shares Held

155M

Call Options Held

2.69M

Put Options Held

1.03M

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $10.2B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Ionis Pharmaceuticals Inc Transaction History